RUBIFEN LA methylphenidate hydrochloride 60 mg modified release capsules blister pack - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
RUBIFEN LA methylphenidate hydrochloride 60 mg modified release capsules blister pack
AUST R: 362234
Active ingredients:
methylphenidate hydrochloride

Dosage form:
Capsule, hard

Sponsor:
AFT Pharmaceuticals Pty Ltd

Phone:
02 94200420

From
18 Apr 2025
to
31 Oct 2026

Shortage status:
Current

Availability:
Unavailable

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
Alternative brands are available. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products